Feb 05, Kathmandu- Cancer patients in the UK have participated in a global trial of an anti-cancer vaccine. Patients participating in this will receive a vaccine that can identify cancer cells in the body and fight against them. This vaccine has been manufactured by the American firm Moderna.

An 81-year-old man with melanoma at Imperial College Healthcare NHS Trust has been given the vaccine, named mRNA-4359. This trial will look at the safety of the vaccine and how effective the vaccine is against melanoma, lung cancer and other tumor cancers.

This vaccine aims to strengthen the immune system and make it fight against cancer. The purpose of the initial phase of the trial is to evaluate the safety and tolerability of the mRNA therapy when the vaccine is used alone or in combination with pembrolizumab, a drug currently used in the treatment of cancer.